title: Prognosis and sequela in patients with childhood craniopharyngioma -- results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000.
abstract: The overall survival rate of patients with craniopharyngioma, an embryogenic malformation, is high (0.92 +/- 0.03). However, there is considerable morbidity and impaired quality of life, even when the tumor can be completely resected. Aim of our study was to analyze risk factors for severe obesity (body mass index [BMI] > or = 7 SD) and the prognosis of severely obese survivors of childhood craniopharyngioma recruited in our cross-sectional study on 183 patients (HIT-ENDO) and in the prospective study KRANIOPHARYNGEOM 2000. Severe obesity (BMI > or = 7 SD) was present in 16 % of patients and associated with higher tumor volume (p < 0.05), more frequent neurosurgical interventions (p < 0.05) and a higher rate of hypothalamic involvement (p < 0.001). Self-assessed functional capacity (FMH) was lower (p < 0.001) in severely obese survivors (FMH: median 33, range: 4-64) when compared with normal weight patients (FMH: 50; 1-95). Overall survival (20 years) was lower (p = 0.034) in patients with severe obesity in comparison to patients with moderate obesity and normal weight. Cardiovascular morbidity and mortality was high in severely obese patients. Between 10/01 and 03/04 fifty-seven patients (27 female/30 male) were recruited in KRANIOPHARYNGEOM 2000 (www.kraniopharyngeom.com). The impact of tumor localization (3.2 % intrasellar, 22.6 % suprasellar, 74.2 % combined intra/suprasellar; 51.6 % hypothalamic involvement) and treatment (26 complete resections, 22 partial resections followed by irradiation in one case; primary irradiation after biopsy in one case) on quality of life, functional capacity and prognosis will be evaluated longitudinally and prospectively.
authors.affiliation: Klinik für Allgemeine Kinderheilkunde, Hämatologie/Onkologie, Zentrum für Kinder- und Jugendmedizin, Klinikum Oldenburg gGmbH, Oldenburg. mueller.hermann@klinikum-oldenburg.de
authors.forename: H L
authors.initials: HL
authors.lastname: Müller
authors.forename: U
authors.initials: U
authors.lastname: Gebhardt
authors.forename: N
authors.initials: N
authors.lastname: Etavard-Gorris
authors.forename: E
authors.initials: E
authors.lastname: Korenke
authors.forename: M
authors.initials: M
authors.lastname: Warmuth-Metz
authors.forename: R
authors.initials: R
authors.lastname: Kolb
authors.forename: N
authors.initials: N
authors.lastname: Sörensen
authors.forename: G
authors.initials: G
authors.lastname: Calaminus
mesh_terms: D000293:Adolescent; D000328:Adult; D015992:Body Mass Index; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003397:Craniopharyngioma / Q000150:complications / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D003430:Cross-Sectional Studies; D003627:Data Interpretation, Statistical; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007031:Hypothalamus; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D015337:Multicenter Studies as Topic; D009765:Obesity / Q000209:etiology*; D010911:Pituitary Neoplasms / Q000150:complications / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D011379:Prognosis; D011446:Prospective Studies; D011788:Quality of Life; D012307:Risk Factors; D016019:Survival Analysis; D013997:Time Factors